121 related articles for article (PubMed ID: 31938340)
1. Overexpression of ANGPTL2 and LILRB2 as predictive and therapeutic biomarkers for metastasis and prognosis in colorectal cancer.
He J; Xu J; Yu X; Zhu H; Zeng Y; Fan D; Yi X
Int J Clin Exp Pathol; 2018; 11(5):2281-2294. PubMed ID: 31938340
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract][Full Text] [Related]
4. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer.
Liu X; Qin J; Nie J; Gao R; Hu S; Sun H; Wang S; Pan Y
Front Immunol; 2023; 14():1185208. PubMed ID: 37691929
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL2 Induces Synovial Inflammation via LILRB2.
Nishiyama S; Hirose N; Yanoshita M; Takano M; Kubo N; Yamauchi Y; Onishi A; Ito S; Sakata S; Kita D; Asakawa-Tanne Y; Tanimoto K
Inflammation; 2021 Jun; 44(3):1108-1118. PubMed ID: 33538932
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
[TBL] [Abstract][Full Text] [Related]
7. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
8. Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2.
Yang J; Shen G; Cao J; Zhang J; Gu Y; Zhang X; Jiang X; Luo M; Lu Z
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):42-47. PubMed ID: 35675737
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
Zhou J; Wang J; Wu S; Zhu S; Wang S; Zhou H; Tian X; Tang N; Nie S
Int J Mol Med; 2014 Nov; 34(5):1286-92. PubMed ID: 25174582
[TBL] [Abstract][Full Text] [Related]
10. A motif in LILRB2 critical for Angptl2 binding and activation.
Deng M; Lu Z; Zheng J; Wan X; Chen X; Hirayasu K; Sun H; Lam Y; Chen L; Wang Q; Song C; Huang N; Gao GF; Jiang Y; Arase H; Zhang CC
Blood; 2014 Aug; 124(6):924-35. PubMed ID: 24899623
[TBL] [Abstract][Full Text] [Related]
11. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
12. Relationship between miR-204 and ANGPTL2 expression and diagnosis, pathological stage, and prognosis in patients with colon cancer.
Wang C; Tan R; Peng L; Zhang J
Transl Cancer Res; 2021 Aug; 10(8):3788-3796. PubMed ID: 35116678
[TBL] [Abstract][Full Text] [Related]
13. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
Park HS; Kim BC; Yeo HY; Kim KH; Yoo BC; Park JW; Chang HJ
Oncol Rep; 2018 May; 39(5):2279-2287. PubMed ID: 29498404
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Significances and Prognostic Value of
Fu F; Niu R; Zheng M; Yang X; Fan L; Fu W; Zhang S
J Cancer; 2023; 14(1):24-34. PubMed ID: 36605492
[No Abstract] [Full Text] [Related]
17. Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer.
Toiyama Y; Inoue Y; Shimura T; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Araki T; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2015 May; 35(5):2849-56. PubMed ID: 25964566
[TBL] [Abstract][Full Text] [Related]
18. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 2 as a potential biomarker for colorectal cancer.
Yoshinaga T; Shigemitsu T; Nishimata H; Kitazono M; Hori E; Tomiyoshi A; Takei T; Yoshida M
Mol Clin Oncol; 2015 Sep; 3(5):1080-1084. PubMed ID: 26623054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
